Search

Author/Creator Zhang, Jacob

1. Clinical benefit of ixazomib plus lenalidomide‐dexamethasone in myeloma patients with non‐canonical NF‐κB pathway activation. (1st June 2020)

Authors:
Dash, Ajeeta B.; Zhang, Jacob; Shen, Lei; Li, Bin; Berg, Deborah; Lin, Jianchang; Avet‐Loiseau, Hervé; Bahlis, Nizar J.; Moreau, Philippe; Richardson, Paul G.; Di Bacco, Alessandra
Journal:
European journal of haematology
Issue:
Volume 105:Number 3(2020)
Page Start:
274
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. C‐MYC expression and maturity phenotypes are associated with outcome benefit from addition of ixazomib to lenalidomide‐dexamethasone in myeloma. (15th April 2020)

Authors:
Di Bacco, Alessandra; Bahlis, Nizar J.; Munshi, Nikhil C.; Avet‐Loiseau, Hervé; Masszi, Tamás; Viterbo, Luísa; Pour, Ludek; Ganly, Peter; Cavo, Michele; Langer, Christian; Kumar, Shaji K.; Rajkumar, S. Vincent; Keats, Jonathan J.; Berg, Deborah; Lin, Jianchang; Li, Bin; Badola, Sunita; Shen, Lei;...
Journal:
European journal of haematology
Issue:
Volume 105:Number 1(2020)
Page Start:
35
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search